Peter Molloy
Founder, Executive Chairman at Firebrick Pharma- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Firebrick Pharma
-
Australia
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Founder, Executive Chairman
-
Apr 2012 - Present
-
-
-
Swinburne University of Technology
-
Australia
-
Higher Education
-
700 & Above Employee
-
Adjunct Teaching Fellow, Entrepreneurship & Innovation
-
Jul 2015 - Present
-
-
-
Race Oncology
-
Australia
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Founder, Managing Director & CEO
-
Nov 2015 - May 2020
Founding CEO of drug development biotech company focused on oncology (ASX: RAC) Founding CEO of drug development biotech company focused on oncology (ASX: RAC)
-
-
-
Aviragen Therapeutics
-
Research Services
-
1 - 100 Employee
-
Managing Director & CEO
-
Jul 2002 - Dec 2005
CEO of leading ASX-listed biotech company engaged in pharmaceutical drug discovery and development. CEO of leading ASX-listed biotech company engaged in pharmaceutical drug discovery and development.
-
-
-
-
President & CEO
-
Jan 2000 - Jun 2002
CEO of private US biotech company engaged in oncology drug discovery and development. CEO of private US biotech company engaged in oncology drug discovery and development.
-
-
-
-
Managing Director & CEO
-
Sep 1998 - Jan 2000
CEO of Australian/European biotech company engaged in R&D of floriculture GMOs. CEO of Australian/European biotech company engaged in R&D of floriculture GMOs.
-
-
-
Pharmacia & Upjohn
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Vice President Strategic Marketing
-
Jan 1996 - Dec 1997
Top 20 global pharmaceutical company, now owned by Pfizer. Responsible for marketing strategy across 23 countries in Asia-Pacific and Latin America Top 20 global pharmaceutical company, now owned by Pfizer. Responsible for marketing strategy across 23 countries in Asia-Pacific and Latin America
-
-
-
-
Managing Director
-
Jul 1991 - Dec 1995
Managing Director of AU/NZ subsidiary of international pharmaceutical company. 140 employees, based in Sydney. Managing Director of AU/NZ subsidiary of international pharmaceutical company. 140 employees, based in Sydney.
-
-
-
-
General Manager
-
Oct 1989 - Jun 1991
Australia's largest supplier of scientific and medical equipment and supplies, 320 employees; acquired by Alesco Corporation. Australia's largest supplier of scientific and medical equipment and supplies, 320 employees; acquired by Alesco Corporation.
-
-
-
-
President
-
Sep 1987 - Sep 1989
NASDAQ-listed drug delivery biotech based in Boston MA; taken private in 1997. NASDAQ-listed drug delivery biotech based in Boston MA; taken private in 1997.
-
-
-
Faulding Pharmaceuticals
-
Pharmaceutical Manufacturing
-
1 - 100 Employee
-
Product Manager, Division Manager
-
Jul 1978 - Aug 1987
Management of the Medical Products Division, notably including the Betadine range in Australia and NZ Management of the Medical Products Division, notably including the Betadine range in Australia and NZ
-
-